EUSA Pharma, an oncology- focused pharmaceutical group, has named Rolf Hoffman as its new director, it was reported yesterday.

Presently, Hoffman is the chairman of Biotest and sits on the board of directors of Genmab. He brings more than 30 years of pharmaceutical experience to his new position, having served in a number of senior roles in the industry. He most recently spent 12 years with Amgen as its senior vice president of commercial operations, US and prior to that, he worked for SVP.

In the new role, the new director will be involved in guiding EUSA's commercial strategy for its cancer treatments.